Severe SARS‐CoV‐2 infection in a 32‐week pregnant woman treated with Remdesivir‐Dexamethasone combination therapy: A case report

This study shows that remdesivir and dexamethasone combination therapy can be considered as a suitable treatment choice for pregnant women infected with COVID‐19. It is worth mentioning that more studies are required to evaluate the efficacy and side effects of remdesivir monotherapy and its combina...

Descripción completa

Detalles Bibliográficos
Autores principales: Alavi, Seyed Mohammad Amin, Bahrami, Samaneh, Najafian, Mahin, Hoori, Mina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366936/
https://www.ncbi.nlm.nih.gov/pubmed/35979383
http://dx.doi.org/10.1002/ccr3.6241
_version_ 1784765677716897792
author Alavi, Seyed Mohammad Amin
Bahrami, Samaneh
Najafian, Mahin
Hoori, Mina
author_facet Alavi, Seyed Mohammad Amin
Bahrami, Samaneh
Najafian, Mahin
Hoori, Mina
author_sort Alavi, Seyed Mohammad Amin
collection PubMed
description This study shows that remdesivir and dexamethasone combination therapy can be considered as a suitable treatment choice for pregnant women infected with COVID‐19. It is worth mentioning that more studies are required to evaluate the efficacy and side effects of remdesivir monotherapy and its combination with dexamethasone during pregnancy.
format Online
Article
Text
id pubmed-9366936
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93669362022-08-16 Severe SARS‐CoV‐2 infection in a 32‐week pregnant woman treated with Remdesivir‐Dexamethasone combination therapy: A case report Alavi, Seyed Mohammad Amin Bahrami, Samaneh Najafian, Mahin Hoori, Mina Clin Case Rep Case Report This study shows that remdesivir and dexamethasone combination therapy can be considered as a suitable treatment choice for pregnant women infected with COVID‐19. It is worth mentioning that more studies are required to evaluate the efficacy and side effects of remdesivir monotherapy and its combination with dexamethasone during pregnancy. John Wiley and Sons Inc. 2022-08-11 /pmc/articles/PMC9366936/ /pubmed/35979383 http://dx.doi.org/10.1002/ccr3.6241 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Alavi, Seyed Mohammad Amin
Bahrami, Samaneh
Najafian, Mahin
Hoori, Mina
Severe SARS‐CoV‐2 infection in a 32‐week pregnant woman treated with Remdesivir‐Dexamethasone combination therapy: A case report
title Severe SARS‐CoV‐2 infection in a 32‐week pregnant woman treated with Remdesivir‐Dexamethasone combination therapy: A case report
title_full Severe SARS‐CoV‐2 infection in a 32‐week pregnant woman treated with Remdesivir‐Dexamethasone combination therapy: A case report
title_fullStr Severe SARS‐CoV‐2 infection in a 32‐week pregnant woman treated with Remdesivir‐Dexamethasone combination therapy: A case report
title_full_unstemmed Severe SARS‐CoV‐2 infection in a 32‐week pregnant woman treated with Remdesivir‐Dexamethasone combination therapy: A case report
title_short Severe SARS‐CoV‐2 infection in a 32‐week pregnant woman treated with Remdesivir‐Dexamethasone combination therapy: A case report
title_sort severe sars‐cov‐2 infection in a 32‐week pregnant woman treated with remdesivir‐dexamethasone combination therapy: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366936/
https://www.ncbi.nlm.nih.gov/pubmed/35979383
http://dx.doi.org/10.1002/ccr3.6241
work_keys_str_mv AT alaviseyedmohammadamin severesarscov2infectionina32weekpregnantwomantreatedwithremdesivirdexamethasonecombinationtherapyacasereport
AT bahramisamaneh severesarscov2infectionina32weekpregnantwomantreatedwithremdesivirdexamethasonecombinationtherapyacasereport
AT najafianmahin severesarscov2infectionina32weekpregnantwomantreatedwithremdesivirdexamethasonecombinationtherapyacasereport
AT hoorimina severesarscov2infectionina32weekpregnantwomantreatedwithremdesivirdexamethasonecombinationtherapyacasereport

Ejemplares similares